(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-13 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 808390
| Date | Daily Closing Price | Open | High | Low | Volume |
| 13 Wed Nov 2024 | 96.88 | 98.00 | 100.23 | 96.83 | 0.453 times |
| 12 Tue Nov 2024 | 96.62 | 98.60 | 100.85 | 96.52 | 0.56 times |
| 11 Mon Nov 2024 | 99.87 | 102.07 | 103.55 | 99.41 | 0.563 times |
| 08 Fri Nov 2024 | 100.83 | 101.58 | 101.97 | 98.95 | 0.773 times |
| 07 Thu Nov 2024 | 101.39 | 99.33 | 102.47 | 98.59 | 0.863 times |
| 06 Wed Nov 2024 | 99.63 | 100.00 | 101.48 | 98.41 | 1.194 times |
| 05 Tue Nov 2024 | 97.55 | 91.00 | 97.67 | 91.00 | 1.162 times |
| 04 Mon Nov 2024 | 91.88 | 90.70 | 93.00 | 89.50 | 0.718 times |
| 01 Fri Nov 2024 | 90.70 | 87.53 | 90.85 | 87.28 | 0.766 times |
| 31 Thu Oct 2024 | 87.51 | 89.23 | 89.61 | 87.31 | 1.033 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 97.3 as stoploss in an intra day sell trade for a target of 90.62. However, stock will show a bullish move above 97.3.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 80.68 |
| Downside Target | 83.91 |
| Downside Target | 87.24 |
| Downside Target | 89.35 |
| Downside Target | 94.98 |
| Downside Target | 96.52 |
| Upside Target | 102.47 |
| Upside Target | 103.55 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 94.42 |
| Downside Intraday Target | 91.95 |
| Upside Intraday Target | 101.45 |
| Upside Intraday Target | 106.01 |
| Upside Intraday Target | 98.98 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 13 Wed Nov 2024 | 96.88 | 102.07 | 103.55 | 96.52 | 0.335 times |
| 08 Fri Nov 2024 | 100.83 | 90.70 | 102.47 | 89.50 | 0.733 times |
| 01 Fri Nov 2024 | 90.70 | 83.33 | 94.98 | 80.68 | 1.761 times |
| 25 Fri Oct 2024 | 82.47 | 85.78 | 87.24 | 81.22 | 1.174 times |
| 18 Fri Oct 2024 | 86.00 | 87.61 | 91.16 | 85.12 | 1.085 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 13 Wed Nov 2024 | 96.88 | 87.53 | 103.55 | 87.28 | 0.392 times |
| 31 Thu Oct 2024 | 87.51 | 91.63 | 94.98 | 80.68 | 1.055 times |
| 30 Mon Sep 2024 | 92.50 | 94.80 | 96.50 | 83.91 | 0.853 times |
| 30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term and the buy signal is strong.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 96.21 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Blueprint Medicines stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Blueprint Medicines in short term and the buy signal is strong.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a SELL signal for Blueprint Medicines in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Blueprint Medicines is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 96.21 and Blueprint Medicines (BPMC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.